These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 22325320

  • 1. Bioactive silica-based drug delivery systems containing doxorubicin hydrochloride: in vitro studies.
    Prokopowicz M, Zegliński J, Gandhi A, Sawicki W, Tofail SA.
    Colloids Surf B Biointerfaces; 2012 May 01; 93():249-59. PubMed ID: 22325320
    [Abstract] [Full Text] [Related]

  • 2. Bioactive silica-based nanomaterials for doxorubicin delivery: evaluation of structural properties associated with release rate.
    Prokopowicz M.
    Mater Sci Eng C Mater Biol Appl; 2013 Oct 01; 33(7):3942-50. PubMed ID: 23910300
    [Abstract] [Full Text] [Related]

  • 3. Correlation between physicochemical properties of doxorubicin-loaded silica/polydimethylsiloxane xerogel and in vitro release of drug.
    Prokopowicz M.
    Acta Biomater; 2009 Jan 01; 5(1):193-207. PubMed ID: 18755642
    [Abstract] [Full Text] [Related]

  • 4. Formulation, characterisation and in vitro studies of doxorubicin-loaded silica-polydimethylsiloxane granules.
    Prokopowicz M.
    Eur J Pharm Sci; 2015 Jan 23; 66():10-9. PubMed ID: 25281914
    [Abstract] [Full Text] [Related]

  • 5. In-vitro controlled release of doxorubicin from silica xerogels.
    Prokopowicz M.
    J Pharm Pharmacol; 2007 Oct 23; 59(10):1365-73. PubMed ID: 17910811
    [Abstract] [Full Text] [Related]

  • 6. Sol-gel processing of anti-inflammatory entrapment in silica, release kinetics, and bioactivity.
    Catauro M, Melisi D, Curcio A, Rimoli MG.
    J Biomed Mater Res A; 2008 Dec 15; 87(4):843-9. PubMed ID: 18200553
    [Abstract] [Full Text] [Related]

  • 7. Preparation and in vitro characterisation of bioactive mesoporous silica microparticles for drug delivery applications.
    Prokopowicz M, Czarnobaj K, Szewczyk A, Sawicki W.
    Mater Sci Eng C Mater Biol Appl; 2016 Mar 15; 60():7-18. PubMed ID: 26706501
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Surface-Activated Fibre-Like SBA-15 as Drug Carriers for Bone Diseases.
    Prokopowicz M, Żeglinski J, Szewczyk A, Skwira A, Walker G.
    AAPS PharmSciTech; 2018 Dec 20; 20(1):17. PubMed ID: 30574669
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bioactive PMMA bone cement prepared by modification with methacryloxypropyltrimethoxysilane and calcium chloride.
    Miyazaki T, Ohtsuki C, Kyomoto M, Tanihara M, Mori A, Kuramoto K.
    J Biomed Mater Res A; 2003 Dec 15; 67(4):1417-23. PubMed ID: 14624530
    [Abstract] [Full Text] [Related]

  • 13. Nanostructured materials based on mesoporous silica and mesoporous silica/apatite as osteogenic growth peptide carriers.
    Mendes LS, Saska S, Martines MA, Marchetto R.
    Mater Sci Eng C Mater Biol Appl; 2013 Oct 15; 33(7):4427-34. PubMed ID: 23910362
    [Abstract] [Full Text] [Related]

  • 14. Mesoporous silica nanoparticles combining Au particles as glutathione and pH dual-sensitive nanocarriers for doxorubicin.
    Xu S, Li Y, Chen Z, Hou C, Chen T, Xu Z, Zhang X, Zhang H.
    Mater Sci Eng C Mater Biol Appl; 2016 Feb 15; 59():258-264. PubMed ID: 26652372
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Formulation and In Vitro Characterization of Bioactive Mesoporous Silica with Doxorubicin and Metronidazole Intended for Bone Treatment and Regeneration.
    Czarnobaj K, Prokopowicz M, Sawicki W.
    AAPS PharmSciTech; 2017 Nov 15; 18(8):3163-3171. PubMed ID: 28534298
    [Abstract] [Full Text] [Related]

  • 18. Mesoporous silica/apatite nanocomposite: special synthesis route to control local drug delivery.
    Sousa A, Souza KC, Sousa EM.
    Acta Biomater; 2008 May 15; 4(3):671-9. PubMed ID: 18206431
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Novel mesoporous silica-based antibiotic releasing scaffold for bone repair.
    Shi X, Wang Y, Ren L, Zhao N, Gong Y, Wang DA.
    Acta Biomater; 2009 Jun 15; 5(5):1697-707. PubMed ID: 19217361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.